Study #2024-1230
Phase 1/2, open-label, multicenter, first-in-human study of DS-3939a in subjects with advanced solid tumors
MD Anderson Study Status
Enrolling
Treatment Agent
DS-3939a
Description
This study will evaluate the safety, tolerability, and efficacy of DS-3939a in participants with advanced solid tumors.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Advanced Solid Tumor, Metastatic Solid Tumor
Study phase:
Physician name:
Sarina Piha-Paul
Department:
Investigational Cancer Therapeutics
For general questions about clinical trials:
1-844-491-2084
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.